Palmar plantar erythrodysesthesia historical perspective: Difference between revisions
Jump to navigation
Jump to search
Mchitsazan (talk | contribs) No edit summary |
Mchitsazan (talk | contribs) |
||
| Line 5: | Line 5: | ||
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.<ref>{{Cite journal | In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.<ref>{{Cite journal | ||
| author = [[ | | author = [[R. L. Zuehlke]] | ||
| title = | | title = Erythematous eruption of the palms and soles associated with mitotane therapy | ||
| journal = [[ | | journal = [[Dermatologica]] | ||
| pmid = | | pmid = 4276191 | ||
}}</ref> | }}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:44, 26 June 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D.
Overview
Historical Perspective
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.[1]
References
- ↑ R. L. Zuehlke. "Erythematous eruption of the palms and soles associated with mitotane therapy". Dermatologica. PMID 4276191.